Roche
Swiss pharma giant Roche faces a $60 million tax adjustment after the first court decision involving Australia’s complex transfer pricing rules, which are designed to ensure multinationals pay their fair share of tax.
Swiss pharma giant Roche faces a $60 million tax adjustment after the first court decision involving Australia’s complex transfer pricing rules, which are designed to ensure multinationals pay their fair share of tax.